Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT07438080
Recruiting Not applicable

Concordance and Acceptability of Self-screening Compared to Screening Carried Out by a Health Professional for HPV, a Risk Factor for Anal Cancer, by Swab in People Living With HIV. A Randomized Controlled Crossover Study

NCT07438080 · tracked via the Priya Life Science France tracker
Sponsor
Centre Hospitalier Universitaire de la Réunion
Phase
Not applicable
Started
2025-04-09
Last updated
2026-02-27

Condition(s) studied

HPV

Investigational drug(s) / intervention(s)

Public health workshop in community

Public health workshop in community: 1\) Cervical cancer screening awareness workshops, conducted in small groups through focus groups. -2) Proposal for an HPV self-test (vaginal self-swab to detect high-risk HPV) as part of an individual consultation for participants who are not up-to-date with their cervical cancer screening.

Study summary

Comunity health actions are set up in populations of women aged 30 to 65 in vulnerable situations living in the outlying areas of Reunion Island.

The idea is to evaluate those action on health

Eligibility

Sex
FEMALE
Min age
30 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Aged 30 to 65, * In a vulnerable situation (beneficiary of a state or departmental social service, or referred by a charity), * Resident in one of the two municipalities targeted by the study, * Supported by the social services of one of the two municipalities targeted by the study, * Having agreed to participate in sexual health awareness meetings organized on site Exclusion Criteria: * Refusing to participate in the study * Having had a hysterectomy

Primary outcome measure(s)

  • Rate of women who complete cervical cancer screening after the community health intervention, — 3 months
    Rate of women aged 30 to 65 years living in vulnerable areas of Reunion Island who complete cervical cancer screening (HPV test or Pap smear) within 3months after the community health intervention, as documented in medical records or screening databases.

Trial sites (2)

FacilityCityRegionStatus
Cegidd Saint Paul Saint-Paul France Recruiting
CegiDD Saint Pierre Saint-Pierre France Recruiting

More Centre Hospitalier Universitaire de la Réunion trials in France

CTT on Renogram as an Early Marker of Significant Obstruction in Uretero-pelvic Junction Syndrome Recruiting
Factors Associated With Hospitalization and Severity of Arbovirosis in the Indian Ocean Recruiting
Impact of SMS Reminder on Weight Loss, as Part of a Health Pathway in Patients With Prediabetes (PREDIABCOACH) Recruiting
Evaluation of a Musical Intervention on the Anxiety of Patients With a Diagnosis of Acute Coronary Syndrome in a Pre-Hospital Emergency Situation: MuSCA Randomized Controlled Trial Recruiting
Prospective Analysis of Self Medication With Phytotherapy in Nephropatic Patients. Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07438080 on ClinicalTrials.gov ↗ ← All trials in France